Current:Home > ScamsChinese authorities cancel Argentina friendlies amid Messi backlash -StockHorizon
Chinese authorities cancel Argentina friendlies amid Messi backlash
View
Date:2025-04-22 09:45:00
Chinese authorities have canceled two Argentina friendlies next month amid a growing backlash over Lionel Messi's failure to play in Inter Miami's friendly in Hong Kong.
Last month, the Argentina national team announced two March friendlies in China, the first against Nigeria in Hangzhou and the second against Ivory Coast in Beijing.
But the Hangzhou Sports Bureau said in a statement on Friday that it had pulled the plug on the match that was set for the Olympic Sports Center Stadium.
The following day, the Beijing Football Association nixed the Ivory Coast game, saying in a statement to local media: "Beijing does not plan, for the moment, to organize the match in which Lionel Messi was to participate."
There has been growing anger over the Argentine star's injury-related absence against a Hong Kong select side on Sunday, in part due to his participation in Miami's friendlies before and after the game in Hong Kong. Additionally, Miami head coach Gerardo "Tata" Martino said the day before the match that Messi was "likely" to play.
The government-affiliated Global Times in China released a scathing editorial this week speculating Messi’s absence in Hong Kong was due to “political motives,” and that “external forces deliberately wanted to embarrass Hong Kong through this incident.”
Inter Miami has since apologized for Messi's absence and the event promoter, Tatler Asia, has offered fans a 50 percent refund.
Messi also offered an apology on Chinese social media platform Weibo, saying that his groin injury flared up at the last minute and despite a strong desire to play, he was unable to do so.
"I hope we will have the opportunity to go back [to Hong Kong] one day,” the 36-year-old said.
veryGood! (74131)
Related
- Israel lets Palestinians go back to northern Gaza for first time in over a year as cease
- Where do trafficked animals go after they're rescued? This network could be the answer
- Does candy corn kill 500,000 Americans each Halloween? Yes, according to a thing I read.
- NFL trade deadline winners, losers: 49ers score with Chase Young as Commanders confuse
- 'As foretold in the prophecy': Elon Musk and internet react as Tesla stock hits $420 all
- Robert De Niro loses temper during testimony at ex-assistant's trial: 'This is all nonsense!'
- Baton Rouge company set to acquire Entergy gas distribution business
- Edging into the spotlight: When playing in the background is fame enough
- House passes bill to add 66 new federal judgeships, but prospects murky after Biden veto threat
- UN chief visits tallest mountains in Nepal and expresses alarm over their melting glaciers
Ranking
- In ‘Nickel Boys,’ striving for a new way to see
- 5 Things podcast: Israeli prime minister vows no cease-fire, Donald Trump ahead in Iowa
- Whistleblower says utility should repay $382 million in federal aid given to failed clean coal plant
- What are witch storms? Severe weather pattern could hit Midwest in November
- The Grammy nominee you need to hear: Esperanza Spalding
- House Ethics says update on Santos investigation coming as possible expulsion vote looms
- Minnesota governor eliminates college degree requirement for most state jobs
- 'Live cluster bomblet', ammunition found in Goodwill donation, Wisconsin police say
Recommendation
Stamford Road collision sends motorcyclist flying; driver arrested
Powerful 6.6-earthquake strikes off the coast of Chile and is felt in neighboring Argentina
What 10 states are struggling the most to hire workers? See map.
Bangladesh launches new India-assisted rail projects and thermal power unit amid opposition protests
Trump issues order to ban transgender troops from serving openly in the military
Two Missouri men accused of assaulting officers during riot at the U.S. Capitol charged
Dozens of Afghans who were illegally in Pakistan are detained and deported in nationwide sweeps
Potential cure for sickle cell disease raises few concerns for FDA panel